Parkinson's Disease Trial, Recruiting NCT04724941 Sponsor: University Hospital Schleswig-Holstein Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Recruiting

NCT04724941
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are between 50 and 99 years of age

Who may not be able to join:

  • People who have already been diagnosed with Parkinson's disease at the time of joining the study
  • People who have another significant neurological condition affecting the brain or spinal cord (for example, Multiple Sclerosis)
  • People who have other significant health conditions, such as bone or joint problems, that could affect movement-based tests used in the study
  • People taking part in the optional spinal fluid (lumbar puncture) part of the study who have a tendency to bleed easily or who are taking blood-thinning medications (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Daniela Berg, Prof.Dr., Department for Neurology, University of Kiel

Phone: 004943150023983

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University Hospital Schleswig-Holstein
Registry
ClinicalTrials.gov
Start date
1 June 2021
Est. completion
1 December 2027

Where this trial is recruiting

🇩🇪 Germany

Primary endpoints

Risk marker profile

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov